Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Teng Yao Pharmaceutical is a long-standing Chinese pharmaceutical company specializing in the modernization of Traditional Chinese Medicine (TCM) and the development of biological preparations. Based in Tengchong, Yunnan, the company is particularly famous for its research and commercialization of products derived from Periplaneta americana (American cockroach), including its flagship products Kangfuxin Liquid and Xinmai Long Injection. These products are widely used in China for treating gastrointestinal ulcers, wound healing, and chronic heart failure. The company operates multiple GMP-certified production lines and maintains a significant presence in the cardiovascular and digestive health markets. Yunnan Teng Yao is listed on the National Equities Exchange and Quotations (NEEQ) and continues to integrate traditional herbal wisdom with modern pharmacological standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Teng Yao Pharmaceutical.